Effect of Scrophularia striata plant on episiotomy wound healing in primiparus women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014111619977N1

Enrollment

Registered

2016-09-18

Start date

2014-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Episiotomy.

Interventions

Intervention 1: Intervention group: Drugs made from Scrophularia striata plant. Cream base is containing stearic acid, cetyl alcohol, glycerin, triethanolamine and asprmasty. Initial dose was administ

Treatment - Drugs

Placebo

Intervention group: Drugs made from Scrophularia striata plant. Cream base is containing stearic acid, cetyl alcohol, glycerin, triethanolamine and asprmasty. Initial dose was administered within 24 h

Placebo group: Placebo Cream enter the carrier containing the color fits perfectly similar appearance were provided with medication in appropriate circumstances. Initial dose was administered within 2

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included: Age 18-35years, Age between 37-42 weeks of pregnancy, The fetus with cephalic presentation,, Vaginal delivery with episiotomy has a length of 4-3 cm medial side and Exclusion criteria included: Body mass less than 18.5 and more than 26, Placental, Curettage in the first 24 hours after birth, Symptoms of infection, Anemia, Anal lesions

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Primary outcome 1: Redness. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).;Primary outcome 2: Edema. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).;Primary outcome 3: Ecchymosis. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).;Primary outcome 4: Discharge. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).;Primary outcome 5: Adhesive. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).	—

Measure

Time frame

Primary outcome 1: Redness. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).;Primary outcome 2: Edema. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).;Primary outcome 3: Ecchymosis. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).;Primary outcome 4: Discharge. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).;Primary outcome 5: Adhesive. Timepoint: 5th, 10th and 21th day after delivery. Method of measurement: Observation and examination ((REEDA) scale).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahnaz Najar

School of Nursing and Midwifery,Ahvaz Jundishapur University of Medical Sciences

najarshanaz@yahoo.com+373 8331

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026